Business
Business
Latest Headlines
Top Stories
Breaking News
Earnings
Biotech
Investors
Stock Alerts
IPOs
M&A
Canadian
UK
Wallstreet Events
Industry News
Industry News
Technology
Software
Banking
Automotive
Energy
More
Corp. Calendars
Dividends
Stock Splits
Buybacks
Conference Calls
Earnings Calendar
Earnings Calendar
Pos Pre-announcements
Profit Warnings
Positive Surprise
Negative Surprise
Latest Earnings
FDA Calendars
Drug Approvals
Clinical Trial Calendar
Ratings Changes
Upgrades
Downgrades
Cov Initiations
Cov. Reiterated
Economy
Economic News
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard
Cryptocurrency
Crypto
Cryptocurrency
Blockchain
Markets
Markets
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies
Politics
Politics
US
World
White House
Elections
General News
Forex
Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard
Health
Health
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health
Slide Shows
Entertainment
Entertainment
Top Stories
Music news
Pop
Rock
Classic Rock
Rap/Hip-Hop
Country
Alternative
Oldies
All Genre
Content Licensing
Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services
Premium Services
Premium
Intelligent Investor
Biotech Investor
NEW
Login
More
Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us
Business
Corp. News
Latest Headlines
Biotech
Investors
Stock Alerts
IPOs
M&A
Top Stories
Breaking News
Earnings
Canadian
UK
Wallstreet Events
Industry News
Technology
Software
Banking
Automotive
Energy
More
Corp. Calendars
Dividends
Stock Splits
Buybacks
Conference Calls
Earnings Calendar
Earnings Calendar
Pos Pre-announcements
Profit Warnings
Positive Surprise
Negative Surprise
Latest Earnings
FDA Calendars
Drug Approvals
Clinical Trial Calendar
Ratings Changes
Upgrades
Downgrades
Cov Initiations
Cov. Reiterated
Economy
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard
Crypto
Cryptocurrency
Blockchain
Markets
Market News
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies
Politics
US
World
White House
Elections
General News
Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard
Health
Health News
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health
Slide Shows
Entertainment
Entertainment News
Top Stories
Music News
Pop
Rock
Classic Rock
Rap/Hip-Hop
Country
Alternative
Oldies
All Genre
Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services
Premium
Intelligent Investor
Biotech Investor
Login
More
Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us
Coverage Reiterated
Updated: Wednesday, May 6, 2026 11:43:43 AM
Date
Broker
Company
Symbol
Reiterated
Target
3/4/26
Wedbush
Scholar Rock Holding Corporation
SRRK
Outperform
$56 Up From $50
3/4/26
Wedbush
Prime Medicine, Inc.
PRME
Outperform
$8
3/4/26
Wedbush
PASSAGE BIO, INC.
PASG
Outperform
$32
3/4/26
Wedbush
Immunome, Inc.
IMNM
Outperform
$31
3/4/26
Wedbush
AnaptysBio, Inc.
ANAB
Outperform
$60 Up From $50
3/4/26
Wedbush
TScan Therapeutics, Inc.
TCRX
Outperform
$5 Up From $4
3/4/26
Wedbush
Xencor Inc
XNCR
Outperform
$26
3/4/26
William Blair
Huron Consulting Group Inc.
HURN
Outperform
N/A
3/3/26
Wedbush
Rocket Pharmaceuticals, Inc.
RCKT
Outperform
$16
3/3/26
Wedbush
Tyra Biosciences, Inc.
TYRA
Outperform
$53
3/2/26
Wedbush
Disc Medicine, Inc.
IRON
Outperform
$68
3/2/26
William Blair
Exelixis, Inc.
EXEL
Outperform
N/A
3/2/26
William Blair
Evommune, Inc
EVMN
Outperform
N/A
3/2/26
Wedbush
Intellia Therapeutics, Inc.
NTLA
Neutral
$12
3/2/26
Wedbush
Apogee Therapeutics, Inc.
APGE
Outperform
$95 Up From $90
2/27/26
Wedbush
NetApp Inc.
NTAP
Neutral
$115
2/27/26
Wedbush
National CineMedia Inc.
NCMI
Outperform
$6.50
2/27/26
Wedbush
Fate Therapeutics, Inc
FATE
Outperform
$7
2/27/26
Wedbush
D-Wave Quantum Inc.
QBTS
Outperform
$40
2/27/26
Wedbush
TaskUs, Inc.
TASK
Outperform
$15
2/27/26
Wedbush
Janux Therapeutics, Inc.
JANX
Outperform
$45
2/27/26
Wedbush
CG Oncology, Inc.
CGON
Outperform
$77
2/26/26
Wedbush
Xencor Inc
XNCR
Outperform
$26
2/26/26
Wedbush
NVIDIA Corporation
NVDA
Outperform
$300 Up From $230
2/26/26
Wedbush
Imax Corp.
IMAX
Outperform
$46
2/26/26
Wedbush
Everpure, Inc.
PSTG
Outperform
$100
2/26/26
Wedbush
REVOLUTION MEDICINES, INC.
RVMD
Outperform
$147
2/26/26
Wedbush
IonQ, Inc.
IONQ
Outperform
$60
2/25/26
Wedbush
NetApp Inc.
NTAP
Neutral
$115
2/25/26
Wedbush
Day One Biopharmaceuticals, Inc.
DAWN
Outperform
$30 Up From $29
2/25/26
Wedbush
Mercadolibre Inc.
MELI
Outperform
$2400 Down From $2600
2/25/26
Wedbush
AMC Entertainment Holdings Inc.
AMC
Outperform
$3
2/25/26
William Blair
Flywire Corp
FLYW
Outperform
N/A
2/25/26
William Blair
Huron Consulting Group Inc.
HURN
Outperform
N/A
2/25/26
William Blair
CAVA Group, Inc.
CAVA
Outperform
N/A
2/25/26
William Blair
LifeStance Health Group, Inc.
LFST
Outperform
N/A
2/25/26
William Blair
CareDx, Inc.
CDNA
Market Perform
N/A
2/25/26
William Blair
Zeta Global Holdings Corp.
ZETA
Outperform
N/A
2/25/26
William Blair
CoStar Group, Inc.
CSGP
Outperform
N/A
2/25/26
William Blair
SPX Technologies Inc.
SPXC
Outperform
N/A
Buy this Content
Editors Pick
Disney Q2 Profit Down, Sees Earnings Growth In FY26, FY27; Plans At Least $8 Bln Buyback; Stock Up
May 06, 2026 07:32 ET
GameStop Offers To Buy EBay In $55.5 Bln Cash, Stock Deal; EBay Shares Gain
May 04, 2026 06:05 ET
Colgate-Palmolive Q1 Profit Down, Backs FY26 Earnings, Sales Growth View; Stock Up
May 01, 2026 08:09 ET
Humana Cuts FY26 EPS View, Backs Adj. Earnings Forecast After Weak Q1 Profit; Stock Drops
April 29, 2026 06:37 ET